Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

This study evaluates the efficacy of capecitabine using data from a large, well-characterised population of patients with metastatic colorectal cancer (mCRC) treated in two identically designed phase III studies. A total of 1207 patients with previously untreated mCRC were randomised to either oral...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cutsem, E Van, Hoff, P M, Harper, P, Bukowski, R M, Cunningham, D, Dufour, P, Graeven, U, Lokich, J, Madajewicz, S, Maroun, J A, Marshall, J L, Mitchell, E P, Perez-Manga, G, Rougier, P, Schmiegel, W, Schoelmerich, J, Sobrero, A, Schilsky, R L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2004
Aiheet:
Clincal
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409640/
https://ncbi.nlm.nih.gov/pubmed/15026800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601676
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia